본문으로 건너뛰기
← 뒤로

Chinese expert consensus on hematologic malignancy karyotyping.

1/5 보강
Clinica chimica acta; international journal of clinical chemistry 2026 Vol.578() p. 120507
Retraction 확인
출처

Yang Z, Chen S, Zhao M, Gao F, Li J, Peng Y, Jiang T, Zhang J, Tang X, Zhang Y, Chen F, Chen H, Chen P, Chen S, Huang X, Jia Y, Xie X, Li C, Li G, Li J, Li Z, Li Z, Liang R, Liu J, Liu L, Long F, Long Z, Lü J, Ma Q, Mao P, Pan B, Pan J, Pan L, Peng X, Qiang X, Ran L, Ren F, Sun X, Wang D, Wang L, Wang S, Wang X, Wang Y, Wang Y, Wang Z, Wei X, Wu Z, Wu M, Wu X, Xiao J, Yang J, Yang Z, Yao Y, Ying Y, Yu Y, Zhang M, Zhang P, Zhang W, Zhou H, Zhou J, Zhu M, Zou L, Mao C, Yang X, Liu Y

📝 환자 설명용 한 줄

Chromosomal karyotype analysis is crucial for diagnosing and managing hematologic malignancies, yet inconsistent protocols compromise reliability.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Yang Z, Chen S, et al. (2026). Chinese expert consensus on hematologic malignancy karyotyping.. Clinica chimica acta; international journal of clinical chemistry, 578, 120507. https://doi.org/10.1016/j.cca.2025.120507
MLA Yang Z, et al.. "Chinese expert consensus on hematologic malignancy karyotyping.." Clinica chimica acta; international journal of clinical chemistry, vol. 578, 2026, pp. 120507.
PMID 40721192

Abstract

Chromosomal karyotype analysis is crucial for diagnosing and managing hematologic malignancies, yet inconsistent protocols compromise reliability. To standardize practices, this consensus integrates international guidelines (WHO, ICC, ELN) with clinical expertise, providing evidence-based recommendations for specimen collection, cell culture, chromosome harvesting, banding techniques, karyotype analysis, and reporting. By establishing uniform operational standards, this initiative seeks to mitigate variability, improve detection rates, and support precision medicine in hematologic malignancies.

MeSH Terms

Humans; Hematologic Neoplasms; Karyotyping; China; East Asian People

같은 제1저자의 인용 많은 논문 (5)